Diagnostic Efficacy and Dosimetry of MNPR-101-DFO*-89Zr in Patients With Solid Tumors
Abroad (travel likely)RecruitingPHASE1
Conditions
Solid Tumor, Adult · Bladder Cancer · Urothelial Carcinoma · Triple-negative Breast Cancer · Lung Cancer · Colorectal Cancer · Gastric Cancer · Ovarian Cancer · Pancreatic Cancer
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Melbourne Theranostic Innovation Centre (MTIC), North Melbourne, Victoria, Australia
Study leads
Prof. Rod Hicks, MD
Principal Investigator
Melbourne Theranostic Innovation Centre (MTIC)